Author

W. E. Matchett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

J. M. Thiede· 3 shared R. A. Langlois· 3 shared T. D. Bold· 3 shared V. D. Menachery· 3 shared M. K. Jenkins· 2 shared A. G. Soerens· 1 shared A. R. Gress· 1 shared B. K. Thielen· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. M. Thiede

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity

W. E. Matchett, V. Joag, J. M. Stolley, F. K. Shephard, C. F. Quarnstrom, C. K. Mickelson, S. Wijeyesinghe, A. G. Soerens, S. Becker, J. M. Thiede, E. Weyu, S. O'Flanagan, J. Walter, M. N. Vu, V. D. Menachery, , D. Masopust

This study shows that a nucleocapsid protein vaccine provides protective immunity against SARS-CoV-2, independent of spike protein targeting, in animal models.

bioRxiv · Apr 26, 2021Immunology

Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium

J. K. Fiege, J. M. Thiede, H. Nanda, W. E. Matchett, P. J. Moore, N. R. Montanari, B. K. Thielen, J. Daniel, E. Stanley, R. C. Hunter, V. D. Menachery, S. S. Shen, T. D. Bold, R. A. Langlois

This study investigates SARS-CoV-2 tropism, antiviral responses, and therapy effectiveness in human airway epithelium using single-cell RNA-sequencing and flow cytometry.

bioRxiv · Oct 19, 2020Microbiology

SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease

T. J. Gniadek, J. M. Thiede, W. E. Matchett, A. R. Gress, K. A. Pape, M. K. Jenkins, V. D. Menachery, R. A. Langlois, T. D. Bold

The paper assesses SARS-CoV-2 neutralization and serology in convalescent plasma from non-severe COVID-19 donors, finding correlations between binding activity and neutralization.

bioRxiv · Aug 7, 2020Immunology